{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "vascular:surgery:oncovascular:sma-resection",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-08T22:45:00.000Z",
    "updated": "2026-01-08T22:45:00.000Z",
    "contributors": ["copilot-agent"],
    "confidence": 0.88,
    "status": "draft",
    "review_required": true
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/oncovascular",
    "type": "procedure",
    "difficulty": "expert",
    "importance": "critical",
    "audience_levels": ["fellow", "attending"]
  },
  "content": {
    "title": "Superior Mesenteric Artery Resection for Cancer",
    "definition": "En bloc resection of superior mesenteric artery with tumor involvement, typically for pancreatic cancer, with arterial reconstruction to maintain intestinal perfusion.",
    "key_concepts": [
      {
        "concept": "Arterial Involvement in Pancreatic Cancer",
        "description": "SMA abutment >180° or encasement traditionally considered unresectable. Select centers now offer resection with reconstruction."
      },
      {
        "concept": "Resectability Criteria",
        "description": "Locally advanced but technically reconstructible. No distant metastases. Good performance status. Optimal neoadjuvant therapy response."
      },
      {
        "concept": "Multidisciplinary Approach",
        "description": "Requires surgical oncology, vascular surgery, interventional radiology collaboration."
      }
    ],
    "preoperative_assessment": {
      "imaging": {
        "cta": "High-quality thin-slice CT with arterial and venous phase",
        "assessment": "Length of involvement, proximal and distal targets for reconstruction"
      },
      "tumor_board": "Multidisciplinary review mandatory",
      "neoadjuvant": "Most patients receive chemotherapy ± radiation before arterial resection"
    },
    "surgical_technique": {
      "exposure": {
        "approach": "Extended Kocher maneuver, root of mesentery exposure",
        "sma_control": "At aortic origin (proximal), beyond tumor (distal)"
      },
      "resection": {
        "en_bloc": "Tumor with SMA segment resected together",
        "margin": "Ensure adequate arterial margins - frozen section if needed"
      },
      "reconstruction": {
        "interposition_graft": {
          "conduit": "Autologous vein (GSV, femoral vein), or PTFE if vein unavailable",
          "technique": "End-to-end anastomosis proximal and distal to resected segment"
        },
        "reimplantation": {
          "indication": "Short segment involvement near origin",
          "technique": "SMA reimplanted to aorta or graft"
        },
        "alternative_inflow": {
          "options": ["Hepatic artery", "Iliac artery with bypass", "Aorta"],
          "selection": "Based on anatomy and concurrent vascular disease"
        }
      },
      "ischemia_time": {
        "tolerance": "Intestines tolerate up to 60-90 minutes warm ischemia",
        "protection": "Cold flush, minimize clamp time, expeditious reconstruction"
      }
    },
    "combined_resections": {
      "sma_pv_smv": "Often combined with portal vein/SMV resection",
      "celiac": "May require celiac resection (relies on GDA collateral via SMA)",
      "sequence": "Usually complete tumor resection, then vascular reconstruction"
    },
    "complications": {
      "graft_thrombosis": {
        "incidence": "5-15%",
        "consequence": "Intestinal infarction if not recognized",
        "management": "Emergent re-exploration, thrombectomy, revision"
      },
      "intestinal_ischemia": "Even with patent graft, reperfusion injury can occur",
      "delayed_gastric_emptying": "Common after pancreatic surgery",
      "mortality": "5-15% at experienced centers"
    },
    "outcomes": {
      "r0_resection_rate": "60-80%",
      "median_survival": "15-25 months with R0 resection",
      "context": "Without resection, survival 6-12 months"
    }
  },
  "relationships": {
    "prerequisites": [
      "vascular:surgery:mesenteric:sma-anatomy",
      "vascular:surgery:techniques:bypass"
    ],
    "related_concepts": [
      "vascular:surgery:oncovascular:portal-vein-resection",
      "vascular:surgery:oncovascular:celiac-resection"
    ],
    "cross_domain_references": [
      {
        "domain": "surgical-oncology/hepatobiliary",
        "concept": "pancreatic-cancer-surgery",
        "relationship": "vascular-component-of"
      }
    ]
  },
  "evidence": {
    "level": "Level 3",
    "sources": [
      {
        "type": "journal",
        "title": "Arterial resection in pancreatic cancer",
        "journal": "Ann Surg",
        "relevance": "primary"
      }
    ]
  },
  "pedagogy": {
    "learning_objectives": [
      "Describe criteria for resectability of SMA-involved pancreatic cancer",
      "Explain surgical technique for SMA resection and reconstruction",
      "List conduit options and their advantages",
      "Discuss outcomes and complications"
    ],
    "clinical_pearls": [
      "Select patients carefully - arterial resection adds significant risk",
      "Neoadjuvant therapy response helps predict benefit",
      "Autologous vein is preferred conduit",
      "Intestine tolerates ~60 minutes ischemia - work efficiently"
    ]
  }
}
